Profile data is unavailable for this security.
About the company
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
- Revenue in USD (TTM)276.67m
- Net income in USD28.19m
- Incorporated2006
- Employees992.00
- LocationTactile Systems Technology Inc1331 Tyler St NE Ste 200MINNEAPOLIS 55413-1638United StatesUSA
- Phone+1 (612) 355-5100
- Fax+1 (612) 355-5101
- Websitehttps://www.tactilemedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delcath Systems Inc | 4.61m | -49.79m | 195.89m | 76.00 | -- | 12.27 | -- | 42.52 | -2.65 | -2.65 | 0.2357 | 0.5747 | 0.1382 | 0.4545 | 4.56 | 60,618.42 | -149.30 | -116.57 | -249.28 | -243.21 | 70.54 | 71.02 | -1,080.73 | -1,235.37 | 2.25 | -42.25 | 0.3348 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
Neuropace Inc | 69.07m | -31.51m | 198.79m | 171.00 | -- | 13.84 | -- | 2.88 | -1.18 | -1.18 | 2.59 | 0.4994 | 0.6735 | 1.62 | 6.63 | 403,935.70 | -30.72 | -- | -34.60 | -- | 73.97 | -- | -45.61 | -- | 5.56 | -4.67 | 0.8019 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
Semler Scientific Inc | 65.88m | 21.69m | 207.24m | 92.00 | 10.56 | 2.61 | 9.28 | 3.15 | 2.78 | 2.78 | 8.45 | 11.26 | 0.855 | 15.13 | 8.51 | 716,097.80 | 28.14 | 38.83 | 31.14 | 44.41 | 89.43 | 90.22 | 32.92 | 32.58 | 12.11 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
Butterfly Network Inc | 68.08m | -121.92m | 209.63m | 225.00 | -- | 1.03 | -- | 3.08 | -0.5893 | -0.5893 | 0.329 | 0.9685 | 0.2045 | 0.6954 | 4.97 | 302,577.80 | -36.61 | -- | -42.07 | -- | 26.50 | -- | -179.08 | -- | 3.34 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
Edap Tms SA (ADR) | 65.63m | -19.77m | 220.95m | 307.00 | -- | 3.85 | -- | 3.37 | -0.534 | -0.534 | 1.77 | 1.55 | 0.6377 | 2.39 | 3.53 | 213,769.90 | -19.21 | -6.62 | -26.95 | -9.22 | 40.91 | 43.23 | -30.12 | -9.59 | 2.00 | -- | 0.0757 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
Senseonics Holdings Inc | 23.30m | -80.59m | 228.28m | 132.00 | -- | 12.04 | -- | 9.80 | -0.1354 | -0.1354 | 0.039 | 0.1067 | 0.1635 | 2.51 | 6.51 | 176,515.20 | -56.55 | -73.65 | -66.90 | -106.97 | 12.93 | -40.41 | -345.89 | -649.86 | 3.70 | -11.13 | 0.4783 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
Utah Medical Products, Inc. | 49.04m | 16.38m | 240.96m | 169.00 | 15.15 | 1.92 | 11.15 | 4.91 | 4.51 | 4.51 | 13.50 | 35.60 | 0.3727 | 2.09 | 13.24 | 290,201.20 | 12.44 | 12.69 | 13.02 | 13.19 | 59.05 | 61.57 | 33.39 | 30.51 | 17.89 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
Orchestra Biomed Holdings Inc | 2.22m | -51.64m | 248.01m | 56.00 | -- | 4.34 | -- | 111.92 | -1.47 | -1.47 | 0.063 | 1.60 | 0.0203 | 1.01 | 30.99 | 39,571.43 | -47.18 | -- | -52.58 | -- | 92.06 | -- | -2,330.46 | -- | 7.33 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
AngioDynamics, Inc. | 324.01m | -192.37m | 252.74m | 815.00 | -- | 1.17 | -- | 0.7801 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
Pulmonx Corp | 72.99m | -58.73m | 281.41m | 279.00 | -- | 2.55 | -- | 3.86 | -1.54 | -1.54 | 1.91 | 2.85 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
AxoGen Inc | 163.73m | -21.28m | 298.50m | 426.00 | -- | 3.20 | -- | 1.82 | -0.4943 | -0.4943 | 3.80 | 2.13 | 0.8709 | 1.49 | 7.04 | 384,333.30 | -11.32 | -13.92 | -12.82 | -15.84 | 78.34 | 79.74 | -13.00 | -20.28 | 2.23 | -8.76 | 0.3346 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
Tactile Systems Technology Inc | 276.67m | 28.19m | 302.49m | 992.00 | 10.76 | 1.56 | 8.71 | 1.09 | 1.18 | 1.18 | 11.70 | 8.14 | 1.01 | 6.77 | 6.05 | 278,896.20 | 10.30 | 0.9015 | 12.18 | 1.09 | 49.98 | 49.10 | 10.19 | 0.8309 | 3.63 | -- | 0.128 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
Zynex Inc | 188.68m | 8.17m | 322.52m | 1.10k | 44.89 | 9.93 | 25.50 | 1.71 | 0.2261 | 0.2261 | 5.39 | 1.02 | 1.59 | 2.52 | 6.56 | 171,530.00 | 6.89 | 14.58 | 8.41 | 17.52 | 80.22 | 79.62 | 4.33 | 10.44 | 2.87 | 7.24 | 0.6381 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
Sight Sciences Inc | 81.50m | -54.75m | 326.40m | 214.00 | -- | 2.98 | -- | 4.01 | -1.12 | -1.12 | 1.67 | 2.20 | 0.4628 | 1.66 | 5.09 | 380,822.40 | -31.09 | -38.78 | -33.65 | -42.20 | 85.73 | 80.74 | -67.18 | -105.14 | 12.42 | -14.76 | 0.2358 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
Nevro Corp | 430.75m | -82.59m | 343.41m | 1.22k | -- | 1.23 | -- | 0.7973 | -2.28 | -2.28 | 11.90 | 7.59 | 0.736 | 1.14 | 6.04 | 354,523.50 | -14.11 | -13.64 | -16.06 | -16.68 | 68.94 | 68.54 | -19.17 | -20.67 | 5.57 | -- | 0.4354 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
Treace Medical Concepts Inc | 196.03m | -54.75m | 364.61m | 516.00 | -- | 2.88 | -- | 1.86 | -0.8885 | -0.8885 | 3.18 | 2.04 | 0.797 | 1.28 | 7.07 | 379,905.00 | -22.26 | -- | -25.98 | -- | 80.99 | -- | -27.93 | -- | 3.22 | -- | 0.2958 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
First Light Asset Management LLCas of 31 Mar 2024 | 2.64m | 11.12% |
Cadian Capital Management LPas of 31 Mar 2024 | 1.93m | 8.12% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.86m | 7.84% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.34m | 5.63% |
Perceptive Advisors LLCas of 31 Mar 2024 | 903.09k | 3.80% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 853.94k | 3.59% |
Dimensional Fund Advisors LPas of 31 Mar 2024 | 829.20k | 3.49% |
Next Century Growth Investors LLCas of 31 Mar 2024 | 718.97k | 3.03% |
Paradigm Capital Management, Inc.as of 31 Mar 2024 | 622.73k | 2.62% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 613.68k | 2.58% |